DocGo Inc posted full-year 2022 and fourth quarter results after the bell Monday, but its 2023 guidance is what caught investors’ attention.
DocGo projects 2023 revenue between $500 million to $510 million, which would represent growth of 14% to 16% over 2022 on an as-reported basis. That figure is well beyond analyst consensus projections of $493.2 million.
The company pointed to “strong demand from its customers for both mobile health and transportation services solutions.”
Shares of DocGo added 4.6% in after-hours trading.
The last-mile mobile health services company posted revenue of $108.8 million for the period ended December 31, down from $121.3 million a year earlier but ahead of the Street's expectation of $103.82 million.
Adjusted EBITDA was $6.8 million, compared to $17.3 million in the 2022 period.
The reason for the fall was a decline in Covid testing revenue. In the fourth quarter of 2021, Covid testing brought in about $50 million in revenue, but in 4Q of 2022 it only generated about $1 million.
Full-year 2022 revenue increased to $440.5 million from $318.7 million in 2021, a 38% jump.
Contact Andrew Kessel at andrew.kessel@proactiveinvestors.com
Follow him on Twitter @andrew_kessel